Involvement of Epithelial and endothelial to mesenchymal transition in tissue remolding of rheumatic diseases
上皮和内皮向间质转化参与风湿性疾病的组织重塑
基本信息
- 批准号:23591451
- 负责人:
- 金额:$ 3.33万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2011
- 资助国家:日本
- 起止时间:2011 至 2013
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The aim of this study is to elucidate the mechanism of EMT and EndoMT in tissue remolding and fibrosis of rheumatic diseases and to develop a new treatment strategy for rheumatic diseases. We conducted immune-staining of skin,lung and kidney tissue from rheumatic disease including rheumatoid arthritis, systemic sclerosis and vasculitis. As a result, a hyperplasia of myofibroblast was observed at the site of prominent progression of tissue fibrosis and vascular remodeling due to endothelial dell proliferation. Immuno-staining revealed both the myoblast and endothelial cells express Wnt10a, suggesting signaling through Wnt10 might involvement in irreversible remodeling in rheumatic diseases. These provocative findings suggest that the inhibition of EndMT/EMT may be a promising target for clinical therapeutic translation in settings such as tissue remodeling which cause of irreversible organ damage in rheumatic deseases.
本研究旨在阐明EMT和EndoMT在风湿性疾病组织重塑和纤维化中的作用机制,为风湿性疾病的治疗提供新的策略。我们对风湿性疾病(包括类风湿性关节炎、系统性硬化症和血管炎)的皮肤、肺和肾组织进行免疫染色。结果,由于内皮细胞增殖,在组织纤维化和血管重塑显著进展的部位观察到肌成纤维细胞增生。免疫组化显示成肌细胞和内皮细胞均表达Wnt 10a,提示通过Wnt 10的信号传导可能参与风湿性疾病的不可逆重塑。这些挑衅性的研究结果表明,EndMT/EMT的抑制可能是一个有前途的目标,临床治疗翻译的设置,如组织重塑,导致不可逆的器官损伤的风湿性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAITO Kazuyoshi其他文献
SAITO Kazuyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAITO Kazuyoshi', 18)}}的其他基金
Novel strategies for treatment of rheumatic diseases by Wnt signal blockades
通过Wnt信号阻断治疗风湿性疾病的新策略
- 批准号:
15K09541 - 财政年份:2015
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The mechanism of inflammation in autoimmune response during the acute phase of Kawasaki disease.
川崎病急性期自身免疫反应的炎症机制。
- 批准号:
22790969 - 财政年份:2010
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
A New treatment strategy using analysis of anti-transcriptional factors antibody in connective tissue diseases.
利用结缔组织疾病抗转录因子抗体分析的新治疗策略。
- 批准号:
20591179 - 财政年份:2008
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Therapeutic strategy for inflammatory diseases by a novel negative regulatory transcriptional factor of inflammatory cytokines
新型炎症细胞因子负调节转录因子治疗炎症性疾病的策略
- 批准号:
18591128 - 财政年份:2006
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Regulation of FOXP3 expression and induction of regulatory T cells for therapeutic application to autoimmune diseases.
分析 FOXP3 表达的调节和调节性 T 细胞的诱导在自身免疫性疾病治疗中的应用。
- 批准号:
16591002 - 财政年份:2004
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Treatment for rheumatoid arthritis with immunogene therapy by angiostatin
血管抑制素免疫基因疗法治疗类风湿性关节炎
- 批准号:
13670486 - 财政年份:2001
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Crystallographic studies on inorganic components of black-and calcium bilirubinate gallstones
黑胆红素胆石和胆红酸钙胆石无机成分的晶体学研究
- 批准号:
08671478 - 财政年份:1996
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chemical and crystallographic characteristics and growth factors of calcium carbonate gallstones.
碳酸钙胆结石的化学和晶体学特征以及生长因子。
- 批准号:
02670586 - 财政年份:1990
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)